Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA Clears GeNO IND Application For Nitrosyl Delivery Platform
GeNO said that the initial indication to be studied for nitric oxide delivered via the GeNO Nitrosyl delivery system is as a diagnostic agent for administration as an
GeNO said that the initial indication to be studied for nitric oxide delivered via the GeNO Nitrosyl delivery system is as a diagnostic agent for administration as an
LCT Biomedical was formed in 2009 to facilitate the commercial development of Diabecell in Russia. Diabecell is designed to normalise the lives of people with insulin dependent diabetes.
EP Scientific said that all of its custom cleaning services and packaging are processed in its certified class 100/10 cleanroom facilities with full traceability and GMP compliant processes.
Total product revenue was $70.2m, a 16% increase compared to $60.6m for the fourth quarter of 2008. Total product revenue for full year 2009 was $232.9m compared to
Ms Hancook, most recently a short-term consultant and contractor, will join Viachem from Intervoice/Convergys where she was director of worldwide corporate communications. She has also headed marketing, business
Allergan said that Botox is a prescription-only medical product that contains tiny amounts of highly purified botulinum toxin protein refined from Clostridium botulinum. Botox has a protected molecular
The deal also includes a purchase price of approximately $722m less Facet’s projected cash and marketable securities at closing of approximately $272m. The acquisition brings access to biologics
The expanded organization provides the biopharmaceutical industry with access to a global CRO that has its focus on the developmental phase between intellectual property (IP) and submission of
The company is the maker of Vagisil brand feminine hygiene products and had been marketing Vagisil deodorant powder in a 7-oz bottle size. The company intended to come
The new R&D facility will service international biologic developments, with combined volumes of bioreactors up to 20,000lt in multiple production lines (trains). Julius Li, CEO of AutekBio, said